Antenatal magnesium sulfate for neuroprotection before preterm birth?

New England Journal of Medicine

Volumn 359, Issue 9, 2008, Pages 962-964

  Stanley, Fiona J ^a   Crowther, Caroline ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE;

CEREBRAL PALSY; DRUG EFFECT; EDITORIAL; HUMAN; NEUROPROTECTION; PERINATAL DEATH; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES;

EID: 50449099851     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe0805018     Document Type: Editorial

References (15)

1. Stanley FJ, Blair E, Alberman E. Cerebral palsies: epidemiology and causal pathways. London: MacKeith Press, 2000.
2. Saigal S, Doyle D. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008;371:261-9.
3. Hamilton BE, Miniño AM, Martin JA, Kochanek KD, Strobino DM, Guyer B. Annual summary of vital statistics: 2005. Pediatrics 2007;119:345-60.
4. Doyle LW, Crowther CA, Middleton P, Marret S. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2007;3:CD004661.
5. Grimes DA, Nanda K. Magnesium sulfate tocolysis: time to quit. Obstet Gynecol 2006;108:986-9.
6. Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev 2002;4:CD001060.
7. Duley L, Gülmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2003;2:CD000025.
8. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 1995;95:263-9.
9. Espinoza MI, Parer JT. Mechanisms of asphyxial brain damage, and possible pharmacologic interventions, in the fetus. Am J Obstet Gynecol 1991;164:1582-9.
10. Paneth N, Jetton J, Pinto-Martin J, Susser M. Magnesium sulfate in labor and risk of neonatal brain lesions and cerebral palsy in low birth weight infants. Pediatrics 1997;99:E1.
11. Crowther CA, Hiller JE, Doyle LW, Haslam RR. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomised controlled trial. JAMA 2003;290:2669-76.
12. Mittendorf R, Dambrosia J, Pryde PG, et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002;186:1111-8.
13. Magpie Trial Follow Up Study Collaborative Group. The Magpie Trial: a randomised trial comparing magnesium sulfate with placebo for pre-eclampsia: outcome for children at 18 months. BJOG 2007;114:289-99.
14. Marret S, Marpeau L, Zupan-Simunek V, et al. Magnesium sulphate given before very-preterm birth to protect infant brain: the randomized, controlled PREMAG trial. BJOG 2007;114:310-8.
15. Rouse DJ, Hirtz DG, Thom E, et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008;359:895-905.